INNODIA 1型糖尿病自然史研究:欧洲新诊断儿童、青少年和成人队列
INNODIA队列纳入649例新诊断1型糖尿病患者,按诊断年龄分<10岁、10–17岁、≥18岁三组,随访12个月。C肽随年龄增长而更高,但所有年龄组均下降且下降速率无主要年龄差异;低基线空腹C肽、BMI SD评分及诊断时糖尿病酮症酸中毒与随访中刺激后C肽更低相关。
要点
- 649例新诊断1型糖尿病患者中96.9%一种或以上糖尿病相关抗体阳性。
- 基线空腹C肽随年龄增长而更高(p<0.001),但所有年龄组C肽均随时间下降。
- 低基线空腹C肽、BMI SD评分及诊断时糖尿病酮症酸中毒与随访中刺激后C肽更低相关。
核心结论
- 在这个大型新诊断1型糖尿病队列中,识别出临床和生化变量存在年龄相关差异。
- 值得注意的是,年幼儿童C肽更低,但其下降速率无主要年龄差异。
研究设计与样本
- 研究基于大型INNODIA队列,纳入年龄1.0–45.0岁新诊断1型糖尿病个体,每3个月随访,评估诊断后前12个月的临床特征、C肽、HbA1c和糖尿病相关抗体及其变化。
- 按年龄分为三组:<10岁、10–17岁、≥18岁。
- 研究人群共649例(57.3%男性;年龄12.1±8.3岁)。
主要发现
- 96.9%的个体一种或以上糖尿病相关抗体阳性。
- 基线(IQR)空腹C肽为242.0(139.0–382.0)pmol/l(AUC 749.3 [466.2–1106.1] pmol/l × min),水平随年龄增长而升高(p<0.001)。
- 随时间推移,<10岁参与者C肽持续更低,但所有年龄组C肽均下降;同时血糖水平逐步升高。
- 较低基线空腹C肽、BMI SD评分及诊断时糖尿病酮症酸中毒与随访中刺激后C肽更低相关。
- HbA1c在诊断后前3个月下降(p<0.001),而胰岛素需求量从诊断后3个月起增加(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 1 diabetes is an heterogenous condition. Characterising factors explaining differences in an individual's clinical course and treatment response will have important clinical and research implications. Our aim was to explore type 1 diabetes heterogeneity, as assessed by clinical characteristics, autoantibodies, beta cell function and glycaemic outcomes, during the first 12 months from diagnosis, and how it relates to age at diagnosis. METHODS: Data were collected from the large INNODIA cohort of individuals (aged 1.0-45.0 years) newly diagnosed with type 1 diabetes, followed 3 monthly, to assess clinical characteristics, C-peptide, HbA1c and diabetes-associated antibodies, and their changes, during the first 12 months from diagnosis, across three age groups: <10 years; 10-17 years; and ≥18 years. RESULTS: The study population included 649 individuals (57.3% male; age 12.1±8.3 years), 96.9% of whom were positive for one or more diabetes-related antibodies. Baseline (IQR) fasting C-peptide was 242.0 (139.0-382.0) pmol/l (AUC 749.3 [466.2-1106.1] pmol/l × min), with levels increasing with age (p<0.001). Over time, C-peptide remained lower in participants aged <10 years but it declined in all age groups. In parallel, glucose levels progressively increased. Lower baseline fasting C-peptide, BMI SD score and presence of diabetic ketoacidosis at diagnosis were associated with lower stimulated C-peptide over time. HbA1c decreased during the first 3 months (p<0.001), whereas insulin requirement increased from 3 months post diagnosis (p<0.001). CONCLUSIONS/INTERPRETATION: In this large cohort with newly diagnosed type 1 diabetes, we identified age-related differences in clinical and biochemical variables. Of note, C-peptide was lower in younger children but there were no main age differences in its rate of decline.
引用
- Marcovecchio ML, Hendriks AEJ, Delfin C, et al. The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults. Diabetologia. 2024. PMID: 38517484. doi:10.1007/s00125-024-06124-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。